PRCT Procept BioRobotics Corp

Price (delayed)

$26.91

Market cap

$1.53B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.82

Enterprise value

$1.36B

?
Relative Growth: Rel. Growth: 61
Relative Strength: Rel. Strength: 17
Relative Valuation: Rel. Valuation: 14
Relative Profitability: Rel. Profitability: 26

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic ...

Highlights
PRCT's gross profit is up by 32% year-on-year and by 5% since the previous quarter
Procept BioRobotics's revenue has increased by 29% YoY and by 4.5% QoQ
The quick ratio has declined by 29% year-on-year and by 4.4% since the previous quarter
Procept BioRobotics's net income has decreased by 14% YoY and by 7% QoQ

Key stats

What are the main financial stats of PRCT

PRCT stock price

How has the Procept BioRobotics stock price performed over time
Intraday
2.2%
1 week
-1.07%
1 month
8.38%
1 year
-56.34%
YTD
-14.46%
QTD
7.6%

Financial performance

How have Procept BioRobotics's revenue and profit performed over time
Revenue
$322.02M
Gross profit
$206.01M
Operating income
-$109.03M
Net income
-$102.47M
Gross margin
64%
Net margin
-31.8%
PRCT's gross profit is up by 32% year-on-year and by 5% since the previous quarter
Procept BioRobotics's revenue has increased by 29% YoY and by 4.5% QoQ
Procept BioRobotics's net income has decreased by 14% YoY and by 7% QoQ
PRCT's operating income is down by 13% year-on-year and by 5% since the previous quarter

Price vs fundamentals

How does PRCT's price correlate with its fundamentals

Growth

What is Procept BioRobotics's growth rate over time

Valuation

What is Procept BioRobotics stock price valuation
P/E
N/A
P/B
4.36
P/S
4.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.24
Procept BioRobotics's EPS has decreased by 8% YoY and by 6% QoQ
PRCT's P/B is 46% below its 5-year quarterly average of 7.9 and 24% below its last 4 quarters average of 5.6
The equity has declined by 11% year-on-year and by 5% since the previous quarter
The stock's price to sales (P/S) is 73% less than its 5-year quarterly average of 17.0 and 35% less than its last 4 quarters average of 7.1
Procept BioRobotics's revenue has increased by 29% YoY and by 4.5% QoQ

Efficiency

How efficient is Procept BioRobotics business performance
The ROE has contracted by 10% from the previous quarter
Procept BioRobotics's return on sales has increased by 10% YoY but it has decreased by 2.1% QoQ
Procept BioRobotics's ROA has decreased by 9% from the previous quarter
PRCT's ROIC is down by 4.1% QoQ and by 2.7% YoY

Dividends

What is PRCT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PRCT.

Financial health

How did Procept BioRobotics financials performed over time
The quick ratio has declined by 29% year-on-year and by 4.4% since the previous quarter
Procept BioRobotics's current ratio has decreased by 25% YoY
The debt is 78% smaller than the equity
The equity has declined by 11% year-on-year and by 5% since the previous quarter
The debt has declined by 4.7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.